Why the study?
Does right ventricular ejection fraction assessed by transthoracic 3D echocardiography predict cardiac outcomes and offer incremental prognostic value over standard clinical and echocardiographic parameters?
Does right ventricular ejection fraction assessed by transthoracic 3D echocardiography predict cardiac outcomes and offer incremental prognostic value over standard clinical and echocardiographic parameters?
3D echocardiography-derived right ventricular ejection fraction provides independent and incremental prognostic value for predicting adverse cardiac outcomes beyond standard clinical and echocardiographic parameters.
No takes yet. Share an insight, caveat, or question.
May refine risk stratification when added to standard parameters; leaves open whether integration alters management or outcomes.
Nagata et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: